2024    2023    2022    2021    2020    2019    2018    2017    2016   

2012

Articles

11 - 

Combined Stimulation with the Tumor Necrosis Factor α and the Epidermal Growth Factor Promotes the Proliferation of Hepatocytes in Rat Liver Cultured Slices.

Francis Finot, Régis Masson, Fabienne Desmots, Catherine Ribault, Nicole Bichet, Joan A. Vericat, Patricia Lafouge, Christiane Guguen-Guillouzo, Pascal Loyer

Combined Stimulation with the Tumor Necrosis Factor α and the Epidermal Growth Factor Promotes the Proliferation of Hepatocytes in Rat Liver Cultured Slices. International Journal of Hepatology, 2012, 2012, pp.785786.

DOI : https://doi.org/10.1155/2012/785786

Pubmed : 23119170

 

12 - 

The treatment response of chronically hepatitis C virus-infected patients depends on interferon concentration but not on interferon gene expression in peripheral blood mononuclear cells.

Catherine François, Cédric Coulouarn, Véronique Descamps, Sandrine Castelain, Etienne Brochot, Agnès Baron, Isabelle Duchaussoy, Dominique Capron, Eric Nguyen-Khac, Gilles Duverlie

The treatment response of chronically hepatitis C virus-infected patients depends on interferon concentration but not on interferon gene expression in peripheral blood mononuclear cells. Antimicrobial Agents and Chemotherapy, 2012, 56 (2), pp.903-8.

DOI : https://doi.org/10.1128/AAC.05646-11

Pubmed : 22123700

 

13 - 

Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results.

Etienne Garin, Laurence Lenoir, Yan Rolland, Julien Edeline, Habiba Mesbah, Sophie Laffont, Philippe Porée, Bruno Clément, Jean-Luc Raoul, Eveline Boucher

Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. Journal of Nuclear Medicine, 2012, 53 (2), pp.255-63.

DOI : https://doi.org/10.2967/jnumed.111.094235

Pubmed : 22302962

 

14 - 

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.

Cécile Guichard, Giuliana Amaddeo, Sandrine Imbeaud, Yannick Ladeiro, Laura Pelletier, Ichrafe Ben Maad, Julien Calderaro, Paulette Bioulac-Sage, Mélanie Letexier, Françoise Degos, Bruno Clément, Charles Balabaud, Eric Chevet, Alexis Laurent, Gabrielle Couchy, Eric Letouzé, Fabien Calvo, Jessica Zucman-Rossi

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.: Genetic landscape of hepatocellular carcinoma. Nature Genetics, 2012, 44 (6), pp.694-8.

DOI : https://doi.org/10.1038/ng.2256

Pubmed : 22561517

 

15 - 

Inhibition of Wnt/β-catenin signaling by a soluble collagen-derived frizzled domain interacting with Wnt3a and the receptors frizzled 1 and 8.

Ismaïl Hendaoui, Elise Lavergne, Heun-Sik Lee, Seong Hyun Hong, Hak-Zoo Kim, Christelle Parent, Nathalie Heuzé-Vourc'H, Bruno Clément, Orlando Musso

Inhibition of Wnt/β-catenin signaling by a soluble collagen-derived frizzled domain interacting with Wnt3a and the receptors frizzled 1 and 8. PLoS ONE, 2012, 7 (1), pp.e30601.

DOI : https://doi.org/10.1371/journal.pone.0030601

Pubmed : 22303445

 

16 - 

Carbon tetrachloride-mediated lipid peroxidation induces early mitochondrial alterations in mouse liver.

Laetitia Knockaert, Alain Berson, Catherine Ribault, Pierre-Emmanuel Prost, Alain Fautrel, Julie Pajaud, Sylvie Lepage, Catherine Lucas-Clerc, Jean-Marc Bégué, Bernard Fromenty, Marie-Anne Robin

Carbon tetrachloride-mediated lipid peroxidation induces early mitochondrial alterations in mouse liver. Laboratory Investigation, 2012, 92 (3), pp.396-410.

DOI : https://doi.org/10.1038/labinvest.2011.193

Pubmed : 22157718

 

17 - 

Sensitization of ovarian carcinoma cells with zoledronate restores the cytotoxic capacity of Vγ9Vδ2 T cells impaired by the prostaglandin E2 immunosuppressive factor: implications for immunotherapy.

Vincent Lavoué, Florian Cabillic, Olivier Toutirais, Aurélie Thedrez, Benoît Dessarthe, Cécile Thomas de La Pintière, Pascale Daniel, Fabrice Foucher, Estelle Bauville, Sébastien Henno, Florence Burtin, Jean-Yves Bansard, Jean Levêque, Véronique Catros, Françoise Bouet-Toussaint

Sensitization of ovarian carcinoma cells with zoledronate restores the cytotoxic capacity of Vγ9Vδ2 T cells impaired by the prostaglandin E2 immunosuppressive factor: implications for immunotherapy. International Journal of Cancer, 2012, 131 (4), pp.E449-62.

DOI : https://doi.org/10.1002/ijc.27353

Pubmed : 22095289

 

18 - 

Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization.

Laurence Lenoir, Julien Edeline, Yan Rolland, Marc Pracht, Jean-Luc Raoul, Valérie Ardisson, Patrick Bourguet, Bruno Clément, Eveline Boucher, Etienne Garin

Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization. European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 (5), pp.872-80.

DOI : https://doi.org/10.1007/s00259-011-2033-4

Pubmed : 22237844

 

19 - 

Reduction of β-radiation exposure during preparation of 188Re-labelled Lipiodol for hepatocellular carcinoma treatment.

Nicolas Lepareur, Sophie Laffont, Valérie Ardisson, Nicolas Noiret, Etienne Garin

Reduction of β-radiation exposure during preparation of 188Re-labelled Lipiodol for hepatocellular carcinoma treatment. Nuclear Medicine Communications, 2012, 33 (2), pp.205-8.

DOI : https://doi.org/10.1097/MNM.0b013e32834e7580

Pubmed : 22124362

 

20 - 

(188)Re-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside.

Nicolas Lepareur, Valérie Ardisson, Nicolas Noiret, Etienne Garin

(188)Re-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside. International Journal of Molecular Imaging, 2012, 2012, 278306 (9 p.).

DOI : https://doi.org/10.1155/2012/278306

Pubmed : 22518301